TY  - EJOU
AU  - Richie, Jerome P. 

TI  - Open retroperitoneal lymph node dissection
T2  - Canadian Journal of Urology

PY  - 2005
VL  - 12
IS  - Suppl.1
SN  - 1488-5581

AB  - Testicular cancer has become one of the most curable solid
malignancies. Although chemotherapy can rescue
patients with advanced disease, accurate staging of the
retroperitoneum has been a mainstay of effectiveness of
treatment. Retroperitoneal lymph node dissection via
open technique has been and remains the gold standard
for pathologic staging of the retroperitoneum as well as
effective therapy for patients with minimal nodal
involvement. Retroperitoneal lymphadenectomy has
resulted in a 99.5% tumor survival for patients with
clinical stage I or early stage II disease.<br/>
Alternatives to open retroperitoneal lymph node
dissection include laparoscopic retroperitoneal lymph
node dissection, active surveillance, or primary
chemotherapy. Each of these modalities has a potential
role in selected patients. For the majority of patients,
however, a meticulous retroperitoneal lymph node
dissection gives patients the highest likelihood of survival
with relatively low morbidity.
KW  - testicular cancer
KW  -  retroperitoneal lymph node dissection

DO  -